跳到正文

NextCure, Inc.(NXTC)内部人交易:高管与董事近期交易

过去 18 个月,共有 8 位内部人为 NextCure, Inc.(NXTC)报告了 44 笔 Form 4 交易(最近一笔 2026-11-13)。

日期内部人职务类型股数市值
2026-11-13ADAR1 Capital Management, LLC10% 以上股东买入12,333$62,897
2026-11-13Schneeberger Daniel10% 以上股东买入12,333$62,897
2026-11-09Schneeberger Daniel10% 以上股东买入1,024$5,222
2026-11-09ADAR1 Capital Management, LLC10% 以上股东买入1,024$5,222
2026-11-09Schneeberger Daniel10% 以上股东买入3,662$18,676
2026-11-09ADAR1 Capital Management, LLC10% 以上股东买入3,662$18,676
2026-10-27Schneeberger Daniel10% 以上股东买入5,626$27,170
2026-10-27ADAR1 Capital Management, LLC10% 以上股东买入5,626$27,170
2026-10-27Schneeberger Daniel10% 以上股东买入1,672$8,418
2026-10-27ADAR1 Capital Management, LLC10% 以上股东买入1,672$8,418
2026-10-27Schneeberger Daniel10% 以上股东买入3,553$18,104
2026-10-27ADAR1 Capital Management, LLC10% 以上股东买入3,553$18,104
2026-08-12Ren Jinsheng内部人卖出30,000$184,800
2026-08-12Simcere Zaiming, Inc.内部人卖出30,000$184,800
2026-08-12Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd.内部人卖出30,000$184,800
2026-08-12Simcere Pharmaceutical Group Ltd内部人卖出30,000$184,800
2026-08-12Simcere Zaiming Pharmaceutical Co., Ltd.内部人卖出30,000$184,800
2026-08-12Tang Renhong内部人卖出30,000$184,800
2026-08-03Schneeberger Daniel10% 以上股东买入25,000$120,250
2026-08-03ADAR1 Capital Management, LLC10% 以上股东买入50,000$248,500
2026-08-03Schneeberger Daniel10% 以上股东买入20,000$100,000
2026-08-03ADAR1 Capital Management, LLC10% 以上股东买入20,000$100,000
2026-08-03Schneeberger Daniel10% 以上股东买入20,000$100,000
2026-08-03ADAR1 Capital Management, LLC10% 以上股东买入20,000$100,000
2026-08-03Schneeberger Daniel10% 以上股东买入50,000$248,500

来源:SEC Form 4 申报文件 · 截至 2026-11-13